Beaupre Darrin 4
4 · IDEAYA Biosciences, Inc. · Filed Feb 28, 2023
Insider Transaction Report
Form 4
Beaupre Darrin
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-24+90,000→ 90,000 totalExercise: $17.04Exp: 2033-02-23→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.